ClinicalTrials.gov
ClinicalTrials.gov Menu

Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01270321
Recruitment Status : Active, not recruiting
First Posted : January 5, 2011
Last Update Posted : April 25, 2018
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Taofeek K. Owonikoko, Emory University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : April 2019
  Estimated Study Completion Date : June 2019